Researcher Spotlight: Jianguo Tao, MD, PhD H. Lee Moffitt Cancer and Research Institute Though available therapies for lymphoma are becoming increasingly effective at slowing disease progression and prompting remissions, many patients eventually develop drug resistance that allows their disease…
Researcher Spotlight: Andre Goy, MD, MS John Theurer Cancer Center Dr. Goy is the Chairman and Director of the John Theurer Cancer Center in Hackensack, NJ, where he is also Chief of the Division of Lymphoma. At John Theurer,…
Researcher Spotlight: Paul Barr, MD Wilmot Cancer Institute at the University of Rochester Medical Center Dr. Barr is Assistant Professor of Medicine and Director of the Clinical Trials Office for the Wilmot Cancer Institute at the University of Rochester…
Researcher Spotlight: Thomas M. Habermann, MD Mayo Clinic, Rochester Dr. Thomas Habermann is Professor of Medicine at Mayo Clinic in Rochester and current Chair-Elect of the Lymphoma Research Foundation (LRF) Scientific Advisory Board (SAB). His career as a lymphoma researcher…
Researcher Spotlight: Gita Thanarajasingam, MD Mayo Clinic, Rochester Dr. Thanarajasingam’s LCRMP project proposes a new way of looking at side effects (toxicity) of lymphoma therapies. Many standard lymphoma treatment plans now include therapies that are taken continuously over long…
Researcher Spotlight: Alex Herrera, MD Beckman Research Institute at the City of Hope Dr. Herrera’s project for the Lymphoma Clinical Research Mentoring Program (LCRMP) tests a combination of pembrolizumab (Keytruda) and vorinostat (Zolinza), a histone deacetylase inhibitor (HDAC), in…
Researcher Spotlight: Natalie Galanina, MD The University of Chicago Though ibrutinib (Imbruvica) has helped a large number of lymphoma patients, many patients treated with ibrutinib eventually develop a resistance to the therapy and relapse. Dr. Galanina’s Lymphoma Clinical Research Mentoring…
Researcher Spotlight: Connie Batlevi, MD, PhD Memorial Sloan Kettering Cancer Center Dr. Batlevi’s Lymphoma Clinical Research Mentoring Program (LCRMP) project seeks to capitalize on the success of two classes of novel targeted therapies that have shown effectiveness in lymphoma…
Researcher Spotlight: Lapo Alinari, MD, PhD The Ohio State University Dr. Alinari’s Lymphoma Clinical Research Mentoring Program (LCRMP) project investigates the combination of ibrutinib (Imbruvica) and nivolumab (Opdivo) in relapsed or refractory Hodgkin lymphoma (HL) patients. Nivolumab, a PD-1 checkpoint…
Researcher Spotlight: Sean M. Post, PhD The University of Texas M.D. Anderson Cancer Center Dr. Sean M. Post is an Assistant Professor at The University of Texas M.D. Anderson Cancer Center and a recipient of the Lymphoma Research Foundation’s…